Assessment of per- and polyfluoroalkyl substances (PFAS)
Concerns about potential health risks associated with low-level exposures to PFAS, along with their widespread uses and reported detections in various environmental media… read more
Latest News
Cross-discipline team publishes on Cr(VI) in air
A team of ToxStrategies and EpidStrategies scientists are authors on a manuscript being published in Regulatory Toxicology and Pharmacology. The study examines current… read more
IH Data for TSCA Risk Evaluations
ToxStrategies scientist Kara Franke presented a session on optimizing industrial hygiene data collection and management to inform the US EPA in the TSCA… read more
ToxStrategies Scientists advance understanding of cannabidiol safety data
Cannabidiol (CBD) and other hemp-derived products continue to gain attention from the FDA and consumers. A ToxStrategies team led by Dr. Rayetta Henderson… read more
ToxStrategies scientist receives Distinguished Service Award
Dr. John M. Rogers, ToxStrategies Senior Consultant, has been awarded the 2021 Edward W. Carney Distinguished Service Award by the Society for Birth… read more
EpidStrategies participating in European Hematology Association 2021
EpidStrategies, a division of ToxStrategies, Inc., is excited to be participating in the European Hematology Association Virtual Congress, which will be held virtually from… read more
ToxStrategies Welcomes John M. Rogers, Ph.D.
ToxStrategies is pleased to announce that John M. Rogers, Ph.D., has joined our Health Sciences Practice, following a distinguished career with the U.S…. read more
Nature publishes article on predicting adverse effects to new drugs
ToxStrategies Information Specialist Ms. Seneca Fitch is among a group of scientists from the regulatory community, academia, the pharmaceutical industry, and consulting who have published an… read more